VeriMom¿Es jasminum officinale flower/leaf extract seguro durante el embarazo?
No harmonised reproductive classification found (no H360/H361 in ECHA Annex VI) and no SCCS or CIR reproductive safety warning specific to Jasminum officinale flower/leaf extract. Literature and regulatory sources do not report reproductive or teratogenic effects for the botanical extract; therefore default hazard and mechanism are 0. Topical cosmetics can give low but measurable dermal exposure to botanical extracts (CosIng / PubChem use data), so exposure is scored as low (1). Sources: ECHA Annex VI (no harmonised CLP for this ingredient), CosIng / PubChem, absence of CIR or SCCS repro findings.
Pregnancy-safe products containing jasminum officinale flower/leaf extract
Related ingredients
Frequently asked questions
- ¿Es jasminum officinale flower/leaf extract seguro durante el embarazo?
- No harmonised reproductive classification found (no H360/H361 in ECHA Annex VI) and no SCCS or CIR reproductive safety warning specific to Jasminum officinale flower/leaf extract. Literature and regulatory sources do not report reproductive or teratogenic effects for the botanical extract; therefore default hazard and mechanism are 0. Topical cosmetics can give low but measurable dermal exposure to botanical extracts (CosIng / PubChem use data), so exposure is scored as low (1). Sources: ECHA Annex VI (no harmonised CLP for this ingredient), CosIng / PubChem, absence of CIR or SCCS repro findings.
- ¿Es jasminum officinale flower/leaf extract seguro durante la lactancia?
- No evidence of reproductive/ developmental toxicity or lactation transfer reported in SCCS/CIR or peer‑reviewed literature for this extract. Systemic absorption from typical topical cosmetic use is low but measurable, so breastfeeding exposure is scored as low (1). Sources: CIR (no specific restriction), CosIng, PubChem.
- ¿Es jasminum officinale flower/leaf extract seguro para la piel del bebé?
- No infant‑specific reproductive or developmental hazards identified. Mechanistic data lacking. Because infants (0–3 yr) have higher dermal absorption and surface‑area‑to‑weight ratio, exposure score is increased by +1 relative to adults (adult e=1 → infant e=2). Note: this does not indicate intrinsic reproductive hazard but reflects higher potential exposure through immature skin. Sources: CosIng, PubChem, general toxicological principles on infant skin permeability.
- ¿Cómo puntúa VeriMom a jasminum officinale flower/leaf extract?
- VeriMom puntúa jasminum officinale flower/leaf extract en 93/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a jasminum officinale flower/leaf extract en el embarazo?
- Consulta nuestra lista de alternativas seguras a jasminum officinale flower/leaf extract según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.